<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03585023</url>
  </required_header>
  <id_info>
    <org_study_id>PRUA1GR-2013-00000220</org_study_id>
    <nct_id>NCT03585023</nct_id>
  </id_info>
  <brief_title>Infections and Pregnancy Loss: Correlation Between Abortion and Silent Infections.</brief_title>
  <official_title>Silent Intracellular Infections and Early Pregnancy Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Correlation between the presence of intracellular viruses/bacteria and the incidence of
      miscarriage during the first trimester of pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we will analyse chorionic villi derived from abortion during the first
      trimester of pregnancy (spontaneous abortion vs voluntary pregnancy interruption), in order
      to correlate the presence of infective viruses/bacteria and the incidence of miscarriage.

      The first objective of this project will be to find the viral DNA of HPV, BK and JC
      polyomaviruses and bacterial DNA of Chlamydia trachomatis, Ureaplasma parvum, Ureaplasma
      urealyticum, Mycoplasma hominis in the aborted tissues collected from spontaneous abortions,
      and to compare the prevalence of these DNAs to those derived from elective specimens.

      Acronyms:

      DNA: deoxyribonucleic acid HPV: human papillomavirus PCR: polymerase chain reaction HPyV:
      human polyomavirus PBMC: peripheral blood mononucleated cell BKV: BK polyomavirus JCV: JC
      polyomavirus
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 15, 2014</start_date>
  <completion_date type="Actual">May 14, 2017</completion_date>
  <primary_completion_date type="Actual">November 15, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Individuation of DNA of intracellular agents (viral und bacterial) in chorionic tissue und blood sample.</measure>
    <time_frame>December 2014 - April 2017</time_frame>
    <description>The primary outcome of this project is to find the DNA of viral (HPV, HPyV,BK and JC), or bacterial agents (Chlamydia trachomatis, Ureaplasma parvum, U. urealyticum, Mycoplasma hominis) in samples obtained from spontaneous abortion or elective interruption of pregnancy.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Pregnancy Loss</condition>
  <arm_group>
    <arm_group_label>Spontaneous miscarriage</arm_group_label>
    <description>The study group will be recruited at admission for uterine cavity revision planned for spontaneous abortion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Voluntary pregnancy interruption</arm_group_label>
    <description>The control group will be recruited at admission for uterine cavity revision planned for voluntary pregnancy interruption.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Spontaneous miscarriage</intervention_name>
    <description>Viral DNA and RNA analysis of HPyV and HPV, BKV and JCV. Bacterial DNA and RNA analysis of Chlamydia trachomatis, Ureaplasma parvum, U. urealyticum, Mycoplasma hominis.</description>
    <arm_group_label>Spontaneous miscarriage</arm_group_label>
    <arm_group_label>Voluntary pregnancy interruption</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Voluntary pregnancy interruption</intervention_name>
    <description>Viral DNA and RNA analysis of HPyV and HPV, BKV and JCV. Bacterial DNA and RNA analysis of Chlamydia trachomatis, Ureaplasma parvum, U. urealyticum, Mycoplasma hominis.</description>
    <arm_group_label>Spontaneous miscarriage</arm_group_label>
    <arm_group_label>Voluntary pregnancy interruption</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      All samples, both spontaneous (spontaneous miscarriage) and elective (voluntary interruption
      of pregnancy), will be obtained after uterine cavity curettage.

      All women underwent PBMC extraction from peripheral whole blood.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women who underwent revision of uterine cavity for spontaneous abortion or voluntary
        termination of pregnancy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        I.Inclusion and exclusion criteria

        Inclusion criteria:

          -  age of the patients range from 18 to 42 years old;

          -  gestational age ranging in the first 12 weeks.

        Exclusion criteria:

          -  medical history or laboratory tests positive for sexually transmitted diseases (HIV,
             HBV, HCV, LUE) during the last year;

          -  Congenital or Acquired Immunodeficiency diseases, or immunosuppressive therapies
             during the last year;

          -  Therapeutic abortion (voluntary interruption of pregnancy, law 194 art 6 comma b)

          -  well known causes responsable for spontaneous abortions such as genetic, severe
             uterine or hormonal abnormalities and use of teratogenic drugs.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>June 30, 2018</last_update_submitted>
  <last_update_submitted_qc>June 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Ferrara</investigator_affiliation>
    <investigator_full_name>Angela Graziano</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Fetal Death</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

